Post-operative analgesic efficacy of dexamethasone sodium phosphate versus triamcinolone acetonide in bunionectomy: A prospective, single-blinded pilot randomized controlled trial

Recruiting

• Conditions: Post-operative pain management; Hallux valgus; Anaesthesiology - Pain management

• Registration Number: ACTRN12614000860662
• Lead Sponsor: niversity of Western Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-08-11
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

1.Undergoing surgical correction of hallux valgus facilitated through the UWA Podiatric Surgery Clinic
2.Aged 18 years or older

Exclusion Criteria

1.Cognitive impairment, intellectual disability, physical disability or mental illness
2.Allergy/ hypersensitivity to any corticosteroids
3.Systemic viral and fungal infections
4.Allergy/ hypersensitivity to Prodeine - Registered Trademark 15
5.Diabetes mellitus, inflammatory arthritis and any other forms of immunodeficiency
6.Currently taking medications that can interact with dexamethasone sodium phosphate or triamcinolone acetonide

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time to post-operative analgesic medication assessed through logbook documentation [When patient has a pain score of 3/10 or greater];Pain intensity and interference assessed through the use of Brief Pain Inventory-Short Form (BPI-sf)[Either immediately prior to receiving post-operative analgesic medication or 14 days after the end of the surgery if patient does not require any medication<br><br>The outcome is assessed only at one timepoint. Completing the BPI-sf immediately prior to receiving medications would allow assessment of the patient's pain intensity at its most intolerable state (pain score of 3/10 or greater). Patient would then consume the medication to relieve the pain.<br><br>Patients who do not need to consume any medications (pain score of 2/10 or lesser) would then complete the BPI-sf 14 days after the surgery, indicating no pain or slight pain that do not require consumption of any medication.]

Secondary Outcome Measures

Name	Time	Method
Proportion of participants that received post-operative analgesic medication within each treatment group as assessed through logbook documentation [14 days after the end of the surgery];Total post-operative analgesic consumption assessed through logbook documentation and pill count (the number of pills dispensed – the number of pills counted)[14 days after the end of the surgery]